
|Articles|December 9, 2019
Real-time, High Density Monitoring of pTyr Signaling Targets in Human Tumors Using Heavy Peptide Triggered Targeted Quantitation
Author(s)Thermo Fisher Scientific
Here we describe an internal standard (IS)-guided LC-MS acquisition workflow for reproducible, sensitive and high-density absolute quantification of pTyr signaling.
Trending on LCGC International
1
What FDA’s 2026 Draft Guidance Means for Antibody Drug Conjugates
2
Important Analytical Measurements and Quality by Design for Bioconjugates
3
What Determines a Best-in-Class Antibody Drug Conjugate
4
Framing the Evolving Bioconjugate Landscape
5
